{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:13Z","timestamp":1793924833525,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129260","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:12:04Z","timestamp":1792455124000},"page":"129260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Designing sero-epidemiological studies to explore immune markers associated with a reduced risk of invasive Klebsiella pneumoniae disease"],"prefix":"10.1016","volume":"94","author":[{"given":"Ziyaad","family":"Dangor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchita","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alane","family":"Izu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Olwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Berkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Srikantiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129260_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004233","article-title":"Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: a systematic review of 128 articles across 30 countries","volume":"20","author":"Hu","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.vaccine.2026.129260_bb0010","unstructured":"Combating multidrug-resistant Klebsiella pneumoniae: current therapeutic regimens and future directions, Journal of Antimicrobial Chemotherapy Oxford Academic. https:\/\/academic.oup.com\/jac\/article\/81\/3\/dkag064\/8496198 (accessed April 8, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0015","unstructured":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050 Lancet. https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(24)01867-1\/fulltext (accessed March 16, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0020","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/S2666-5247(23)00290-2","article-title":"Child deaths caused by Klebsiella pneumoniae in sub-Saharan Africa and South Asia: a secondary analysis of child health and mortality prevention surveillance (CHAMPS) data","volume":"5","author":"Verani","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.129260_bb0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries","volume":"6","author":"Sands","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129260_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004179","article-title":"Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS)","volume":"20","author":"Russell","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.vaccine.2026.129260_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100989","article-title":"Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study","volume":"6","author":"Meiring","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.129260_bb0040","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1016\/S2214-109X(22)00246-7","article-title":"Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014\u201319: a cross-sectional study","volume":"10","author":"Mashau","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.vaccine.2026.129260_bb0045","article-title":"Pathogen distribution and antimicrobial resistance among neonatal bloodstream infections in Southeast Asia: results from NeoSEAP, a multicentre retrospective study","volume":"62","author":"Dickson","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2026.129260_bb0050","unstructured":"MICROBE | Institute for Health Metrics and Evaluation. https:\/\/www.healthdata.org\/data-tools-practices\/interactive-visuals\/microbe (accessed May 1, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0055","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1038\/s41598-025-92517-4","article-title":"Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in south African infants","volume":"15","author":"Olwagen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.129260_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/INF.0000000000004177","article-title":"Bacterial and Candida colonization of neonates in a regional Hospital in South Africa","volume":"43","author":"Mabena","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2026.129260_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004239","article-title":"Global, regional, and national estimates of the impact of a maternal Klebsiella pneumoniae vaccine: a Bayesian modeling analysis","volume":"20","author":"Kumar","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.vaccine.2026.129260_bb0070","unstructured":"Transmission Dynamics and Novel Treatments of High Risk Carbapenem-Resistant Klebsiella pneumoniae: The Lens of One Health PMC. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11434721\/ (accessed March 16, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0075","series-title":"Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage","author":"Stanton","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129260_bb0080","author":"CDC"},{"key":"10.1016\/j.vaccine.2026.129260_bb0085","unstructured":"Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | Pfizer. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-advances-pivotal-pediatric-pneumococcal-vaccine (accessed July 22, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0090","doi-asserted-by":"crossref","first-page":"35356","DOI":"10.1021\/jacs.4c13972","article-title":"Semisynthetic glycoconjugate vaccine Lead against Klebsiella pneumoniae serotype O2afg induces functional antibodies and reduces the burden of acute pneumonia","volume":"146","author":"Shen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.vaccine.2026.129260_bb0095","unstructured":"Klebsiella pneumoniae vaccines: Evolving the blueprint from traditional platforms to mucosal and nanoscale delivery PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/41737463\/ (accessed July 27, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/ijms.116432","article-title":"Bioengineering modification and application of bacterial outer membrane vesicles","volume":"23","author":"Wen","year":"2026","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.vaccine.2026.129260_bb0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.it.2023.08.005","article-title":"Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons","volume":"44","author":"Wantuch","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vaccine.2026.129260_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0928-8244(02)00459-5","article-title":"K-antigen-specific, but not O-antigen-specific natural human serum antibodies promote phagocytosis of Klebsiella pneumoniae","volume":"35","author":"Lepper","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129260_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00176-25","article-title":"The development of functional opsonophagocytic assays to evaluate antibody responses to Klebsiella pneumoniae capsular antigens","volume":"10","author":"Lawrence","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2026.129260_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00680-22","article-title":"The development of immunological assays to evaluate the level and function of antibodies induced by Klebsiella pneumoniae O-antigen vaccines","volume":"8","author":"Wagstaffe","year":"2023","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2026.129260_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41590-018-0106-2","article-title":"Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen","volume":"19","author":"Rollenske","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vaccine.2026.129260_bb0130","article-title":"Klebsiella pneumoniae lipopolysaccharide as a vaccine target and the role of antibodies in protection from disease","volume":"12","author":"Miller","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129260_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100988","article-title":"Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study","volume":"6","author":"Hwang","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.129260_bb0140","series-title":"Association of serum antibody to serotype-specific capsular (K), lipopolysaccharide (O) and MrkA with risk reduction of invasive Klebsiella pneumoniae disease in young infants: an observational study","author":"Izu","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129260_bb0145","unstructured":"Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Q\u03b2 virus-like particles, npj Vaccines https:\/\/www.nature.com\/articles\/s41541-023-00744-5 (accessed March 16, 2026)."},{"key":"10.1016\/j.vaccine.2026.129260_bb0150","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1042\/BST20200325","article-title":"The role of Klebsiella populations in preterm infants","volume":"51","author":"McCartney","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.vaccine.2026.129260_bb0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ajic.2012.02.016","article-title":"Pattern of bacterial colonization in a new neonatal intensive care unit and its association with infections in infants","volume":"40","author":"Rastogi","year":"2012","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.vaccine.2026.129260_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity","volume":"2","author":"Fouda","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.vaccine.2026.129260_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127131","article-title":"Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countries","volume":"58","author":"Le Doare","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129260_bb0170","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ije\/dyt083","article-title":"Matched designs and causal diagrams","volume":"42","author":"Mansournia","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2026.129260_bb0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.vaccine.2021.12.007","article-title":"The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis","volume":"40","author":"Oguti","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129260_bb0180","series-title":"Covariate adjusted logit model (CALM) for generating dose-response curves from observational data with applications to vaccine effectiveness trials","author":"Shang","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129260_bb0185","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/sim.2282","article-title":"A model for immunological correlates of protection","volume":"25","author":"Dunning","year":"2006","journal-title":"Stat. Med."},{"key":"10.1016\/j.vaccine.2026.129260_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.0006-341X.2001.00135.x","article-title":"Bayesian inference on protective antibody levels using case-control data","volume":"57","author":"Carey","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2026.129260_bb0195","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The protective value of maternal group B Streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129260_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003350","article-title":"Maternal and neonatal IgG against Klebsiella pneumoniae are associated with lower risk of neonatal sepsis: a case-control study of hospitalized neonates in Botswana","volume":"4","author":"Zhang","year":"2024","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.vaccine.2026.129260_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.37737\/ace.22005","article-title":"Introduction to matching in case-control and cohort studies","volume":"4","author":"Iwagami","year":"2022","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129260_bb0210","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1093\/cid\/ciaa1873","article-title":"Association of group B Streptococcus (GBS) serum serotype-specific anticapsular immunoglobulin G concentration and risk reduction for invasive GBS disease in South African infants: an observational birth-cohort, matched case-control study","volume":"73","author":"Madhi","year":"2021","journal-title":"Clin. Infect. Dis."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:55:40Z","timestamp":1793922940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0264410X26010698"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129260","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing sero-epidemiological studies to explore immune markers associated with a reduced risk of invasive Klebsiella pneumoniae disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129260"}}